当前位置: 首页 > 详情页

Relationship between collateral circulation and myocardial viability of F-18-FDG PET/CT subtended by chronic total occluded coronary arteries

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen road, Chaoyang District, Beijing 100029, China [2]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen road, Chaoyang District, Beijing 100029, China
出处:
ISSN:

关键词: F-18-fluorodeoxyglucose Chronic total occlusion Positron emission tomography Collateral circulation Myocardial viability

摘要:
To analyze the relationship between the collateral flow of coronary chronic total occlusion (CTO) and myocardial viability detected by F-18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging. A prospective analysis of 104 patients diagnosed by coronary angiography. All patients underwent resting myocardial perfusion imaging and PET/CT within 1 week. The collateral circulation was graded with Rentrop classification as no or poor collateral circulation in 16 CTO vessels, moderate collateral circulation in 34 CTO vessels, and good collateral circulation in 69 CTO vessels. Myocardial viability was determined with myocardial perfusion imaging and PET. The patterns were interpreted as mismatch, match and normal perfusion and F-18-FDG uptake. There was no significant correlation between the severity and extent of perfusion defect, myocardial viability and collateral circulation grade. The myocardial viability was normal in mild and moderate hypokinetic regions and decreased in severe hypokinetic and akinesis-dyskinesis regions. The presence of collateral circulation was a sensitive (89%) but not a specific (31%) sign of myocardial viability. In patients with CTO, collateral circulation does not seem to be an effective way for predicting myocardial viability. Further analysis of PET patterns of viable myocardium is needed to guide further revascularization and predict functional improvement and survival benefit.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 核医学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 核医学
JCR分区:
出版当年[2016]版:
Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2024]版:
Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子: 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen road, Chaoyang District, Beijing 100029, China
通讯作者:
通讯机构: [1]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen road, Chaoyang District, Beijing 100029, China [2]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen road, Chaoyang District, Beijing 100029, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17670 今日访问量:1 总访问量:939 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院